Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?

PURPOSE OF REVIEW: COVID-19 patients have a procoagulant state with a high prevalence of thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) has been suggested by several reports. Here, we reviewed 48 studies investigating aPL in COVID-19 patients. RECENT FINDING...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Curr Rheumatol Rep
Glavni autori: Foret, Thomas, Dufrost, Virginie, Salomon Du Mont, Lucie, Costa, Patricia, Lefevre, Benjamin, Lacolley, Patrick, Regnault, Veronique, Zuily, Stephane, Wahl, Denis
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2021
Teme:
Antiphospholipid Syndrome (S Zuily, Section Editor)
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8254447/
https://ncbi.nlm.nih.gov/pubmed/34218350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11926-021-01029-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items